Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05418647
Other study ID # dialysate Na and DRT
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 15, 2023
Est. completion date October 15, 2023

Study information

Verified date June 2023
Source Alexandria University
Contact Mohamed Mamdouh Elsayed, MD
Phone 00201068055103
Email dr_mohamedmamdouh87@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research aims to assess the effect of low versus high dialysate sodium concentration during hemodialysis on dialysis recovery time


Description:

Chronic kidney disease (CKD) is a general term for heterogeneous disorders affecting the structure and function of the kidney. The variation in disease expression is partly related to the cause, pathology, severity and the rate of progression. Fatigue is a well-known and frequent symptom in HD patients with a reported association with the decrease in health-related quality of life commonly found in this population. The prevalence of fatigue ranges from 60% to as high as 97% in patients on long-term renal replacement therapy. Despite this fact, health care providers are still unaware of both its presence and severity. Several methods have been proposed as a way to assess post-HD fatigue with the "time to recover (minutes) from HD" being one of them. Lindsay et al.assisted patients' responses to the single open-ended question, "How long does it take you to recover from a dialysis session?". Although post-HD fatigue commonly exists in dialysis patients, it is usually underestimated by physicians. For this reason, appropriate and early identification of symptoms and associated factors might improve the patient's quality of life. Rayner et al. found that dialysate Na was inversely associated with DRT where lowering the Na concentration in the dialysate (to 140 mEq/L) was linked to a longer DRT.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date October 15, 2023
Est. primary completion date September 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with end-stage renal disease who have been prescribed long term hemodialysis and undergo four-hour HD treatments three times a week for more than 90 days. - Patient must be at least 18 years old. They must be able to read and write, as well as be in complete mental health. Exclusion Criteria: - Inability to complete the surveys due to reading or hearing difficulties, actual instability of clinical condition that necessitate hospitalization, dementia, active malignancy or liver failure.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
high dialysate Na
high dialysate sodium (Na = 141 mmol/L) for 8 weeks
low dialysate Na
low dialysate sodium (Na = 136 mmol/L) for 8 weeks

Locations

Country Name City State
Egypt Faculty of Medicine, Aexandria University Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Alexandria University

Country where clinical trial is conducted

Egypt, 

References & Publications (6)

Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S4-16. doi: 10.1053/j.ajkd.2008.07.048. — View Citation

Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R; Daily Hemodialysis Study Group London Health Sciences Centre. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol. 2006 Sep;1(5):952-9. doi: 10.2215/CJN.00040106. Epub 2006 Jul 6. — View Citation

Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007 Jan;14(1):82-99. doi: 10.1053/j.ackd.2006.10.001. — View Citation

Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2014 Jul;64(1):86-94. doi: 10.1053/j.ajkd.2014.01.014. Epub 2014 Feb 14. — View Citation

Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, Switzer GE. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005 Aug;16(8):2487-94. doi: 10.1681/ASN.2005020157. Epub 2005 Jun 23. — View Citation

Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007 Sep;2(5):960-7. doi: 10.2215/CJN.00990207. Epub 2007 Aug 8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in dialysis recovery time By assessing the patients' responses to the single open-ended question, "How long does it take you to recover from a dialysis session?" baseline, weeks 4 and 8
Secondary Change in plasma sodium concentration measuring plasma sodium concentration baseline, weeks 4 and 8
Secondary Change in the inter-dialytic weight gain measuring the inter-dialytic weight gain 8 weeks
Secondary Change in blood pressure (systolic, diastolic, mean) measuring in blood pressure (systolic, diastolic, mean) 8 weeks
Secondary Occurrence of intradialytic hypotension incidence of intradialytic hypotension 8 weeks
Secondary Occurrence of muscle cramps incidence of muscle cramps 8 weeks
Secondary Occurrence of headache incidence of headache 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT06022835 - Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis N/A
Not yet recruiting NCT05939505 - The Effect of Sujok Therapy on Symptom Burden and Comfort Level in Patients Undergoing Hemodialysis Treatment N/A
Completed NCT05307601 - Immune Response Following COVID-19 in Hemodialysis Patients
Active, not recruiting NCT05287204 - Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT
Recruiting NCT06141798 - Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients N/A
Recruiting NCT04954690 - Structured Program of Exercise for Recipients of Kidney Transplantation N/A
Not yet recruiting NCT05586854 - Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia N/A
Completed NCT05382468 - Effectiveness of Intradialytic Exercise on Reduction in Fatigue and Muscle Cramps N/A
Recruiting NCT05105503 - Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System
Recruiting NCT06374537 - Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients. N/A
Not yet recruiting NCT06360302 - Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients N/A
Completed NCT05564676 - Flaxseed Oil and Pomegranate Extract on Inflammation, Lipid Profile and Nutritional Status of Hemodialysis Patients N/A
Completed NCT05214872 - The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
Not yet recruiting NCT05966116 - Sodium Accumulation Study in Haemodialysis: Brain Study
Recruiting NCT06153888 - ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study N/A
Completed NCT04285775 - A Novel Device for Surveillance of Vascular Access Sites for Bleeding
Not yet recruiting NCT06123806 - Factors Affecting Dialysis Associated Fatigue
Not yet recruiting NCT06446739 - LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) N/A
Recruiting NCT05096195 - PRevEnting FracturEs in REnal Disease 1 Phase 4
Completed NCT04274556 - Recovery Time and Affecting Factors in Hemodialysis Patients